Task order 75N93022F00001 base award
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $764,407
Award facts
- Opportunity
-
- Early Phase Clinical Trial Units (EPCTU) Pre-Solicitation · Posted Nov 19, 2020
- Contract value 39% obligated
-
- $764,407.00 Current, with exercised options
- $1,963,927.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27708, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $193,337 | |
| Exercise an Option | $191,600 | |
| Exercise an Option | $189,914 | |
| Original award | $189,556 |
About this award
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The task order is under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award is for $1,963,927.00 and does not have a set-aside designation. The contract is for a cost-no-fee delivery order, with a period of performance extending to January 13, 2032. Duke University, a private non-profit educational institution, will be the prime contractor providing services related to early-phase clinical trials. No major subcontractors are specified. This award demonstrates Duke's expertise in conducting biomedical research and clinical trials for government agencies like NIAID, which is part of the National Institutes of Health and focuses on infectious diseases and immunology.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 14, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $764,407 on 75N93022F00001. Its potential value, with all options, is $1,963,927.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93022D00019, an indefinite delivery contract, on Early Phase Clinical Trial Units (EPCTU).
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award